Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial Board

    Page :i

    
• • ·Author index

    Page :S91

    

• Free Paper Session 1 (HIS Grants)

  • ·FP1.1 High-throughput sequencing as a tool in the discovery, diagnosis and epidemiology of nosocomial pathogens

    Page :S1

    M.J. Pallen

    
  • ·FP1.2 MRSA origins – a study to identify and determine the role of attributional bias in the control and prevention of MRSA

    Page :S1

    D. Flaxman, G. Rao, E. Morrow, T. Murrells, S. Brearley, P. Griffiths

    
  • ·FP1.3 Longitudinal study of the molecular epidemiology of extended spectrum β-lactamase-producing Escherichia coli

    Page :S1

    T. Stanton, S. Green, A. Tuck, M. Woodward, S. Damoa-Siakwan

    
  • ·FP1.4 Effect of disposable glove type upon the cross-transmission of methicillin-resistant Staphylococcus aureus

    Page :S2

    G. Moore, A.P.R. Wilson

    
  • ·FP1.5 Assessing the effect of antibiotics on asymptomatic MRSA carriage and colonization dynamics using statistical models

    Page :S2

    T. Kypraios, B.S. Cooper, D. Jones, J. Ware, J. Edgeworth, R. Batra, P. O’Neill

    
  • ·FP1.6 The environmental reservoir of bacteria and antibiotic resistance determinants in an intensive care unit

    Page :S2

    G. Kay, D. Edbrooke, T. Smith, G. Mills, K. Stanley, R. Townsend

    

• Free Paper Session 2

  • ·FP2.1 Universal screening for MRSA: Results from a multicentre evaluation across 6 hospitals in Scotland

    Page :S2

    J. Reilly, S. Stewart, A. Smith, T. Stari, G. Allardice, R. Masterton, I. Gould, C. Williams

    
  • ·FP2.2 Objectively improving patient area infection prevention cleaning in 82 hospitals

    Page :S3

    P. Carling, E. Eck, L. Herwalt

    
  • ·FP2.3 Investigations on Scottish isolates of Clostridium difficile PCR ribotype 106 demonstrating high level resistance to Clindamycin

    Page :S3

    J. Coia, D. Brown, H. Mather, E. Yip, G. Douce, C. Wiuff, A. Banks, A. Eastaway

    
  • ·FP2.4 Predicting the duration of symptoms and likelihood of transmission of norovirus – A retrospective study of a large outbreak in a UK teaching hospital

    Page :S3

    D.G. Partridge, M. Raza, H.K. Parsons

    
  • ·FP2.5 Cleaning enhancements and impact on Clostridium difficile control

    Page :S4

    N.M. Brown, G.J. Hughes, R. Ayers, C. Trundle, A. Thompson, O. Sule

    
  • ·FP2.6 Multicellular behaviour and the pathogenesis of Proteus mirabilis catheter associated urinary tract infections

    Page :S4

    N. Holling, D. Lednor, B.V. Jones

    
  • ·FP2.7 Development of an in-vitro model of Staphylococcus aureus biofilm infection with a focus on reduced susceptibility to antibiotics

    Page :S4

    M. Daniel, C. Rahman, W. Ashraf, N. Fergie, K. Shakesheff, J.P. Birchall, R. Bayston

    
  • ·FP2.8 Managing a hospital-wide Clostridium difficile outbreak – moving to the next level

    Page :S5

    R. Cooke, J. Allan, R. Catlin

    

• Free Paper Session 3

  • ·FP3.1 ‘Hand-hygiene champion junior doctor picks up the gauntlet’ a randomized prospective study of 3080 minutes of hand hygiene audit conducted by doctors

    Page :S5

    M. Przybylo, M. Qulaghassi, A. Guleri

    
  • ·FP3.2 Transmission of influenza to health-care workers in intensive care units – could Aerosol generating procedures play a role?

    Page :S5

    K. Thompson, G. Thomson, H. Mittal, S. Parks, B. Dove, S. Speight, J. Walker, J. Pappachan, P. Hoffman, A. Bennett

    
  • ·FP3.3 Successful control of methicillin-resistant Staphylococcus aureus in endemic neonatal intensive care units in a 7-year campaign

    Page :S5

    R.I. Lien, L.H. Su, Y.H. Chou, T.Y. Lin, Y.C. Huang

    
  • ·FP3.4 Is closure of entire wards necessary to control norovirus outbreaks in hospital? Comparing the effectiveness of two infection control strategies

    Page :S6

    D. Orr, E. Illingworth, E. Taborn, D. Fielding, J. Cheesbrough

    
  • ·FP3.5 Staff screening for MRSA: Five year experience in a UK hospital

    Page :S6

    P. Jenks, C. Haill, A. Kearns, A. Adeodu, J. Steer, K. Harling

    
  • ·FP3.6 Ineffective treatment of solidified suction canisters in static autoclaves – Marketing preceding the science?

    Page :S6

    E. Krisiunas

    
  • ·FP3.7 Does a designated isolation ward for Clostridium difficile infection improve patient care and clinical outcome?

    Page :S7

    R. Cooke, A. Clarke, A. Foley

    
  • ·FP3.8 The use of culture based screening as a semi-quantitative predictor of hospital MRSA acquisition

    Page :S7

    P. Everest, K. Hamilton, J. Coia

    

• Outbreak Session 1

  • ·OB1.1 Outbreak of multi-drug resistant Acinetobacter baumannii in cardiothoracic surgical intensive care units

    Page :S7

    A. Chmielarczyk, J. Wójkowska-Mach, E. Synowiec, M. Baran, E. Foryciarz, D. Romaniszyn, P.B. Heczko

    
  • ·OB1.2 Are we throwing caution to the winds? 3-cases of anaphylaxis to chlorhexidine coated central venous catheters at Lancashire cardiac centre

    Page :S8

    A. Guleri, A. Kumar, M. Hartley, D. Roberts

    
  • ·OB1.3 Group A Streptococcus infection cluster in post-operative plastic surgery patients

    Page :S8

    E. Johnson, H.K. Parsons

    
  • ·OB1.4 A prolonged outbreak of MSSA surgical site infections traced to a thoracic nurse with psoriasis

    Page :S8

    T.C. Boswell, C. Yates, S. Holden

    

• Outbreak Session 2

  • ·OB2.1 Investigation of increased surgical site infections among orthopaedic and ophthalmology patients

    Page :S8

    S.J. Dancer, M. Stewart, C. Coulombe, A. Gregori, M. Virdi, D. Allen

    
  • ·OB2.2 A clonal outbreak of Staphylococcus capitis bloodstream infections in a neonatal intensive care unit (NICU) in the United Kingdom

    Page :S9

    N. Virgincar, G. Boden, S. Iyer, R. Hill, C. Honnor, D. Cash, A. Kearns

    
  • ·OB2.3 Investigation into an outbreak of invasive Group A Streptococcal (iGAS) infection at a general hospital in 2010

    Page :S9

    D. Adams, L. Yee, R. Williams, J. Rimmer, A. Bain, A. Heseltine, M. Afza, J. Hendry, C. Pearce, H. Martin

    
  • ·OB2.4 Vancomycin-resistant enterococci (VRE) in a neurosurgical unit; don’t forget to look up!

    Page :S9

    M. Cotter, E.G. Smyth, F. Fitzpatrick, T. Thomas, J. Walshe, C. Finn, F. Duffy, M. Morris-Downes, H. Humphreys

    

• Poster Session 1 – Antimicrobial Therapy and Prophylaxis

  • ·P01.01 Features of developing nosocomial infection in patients with transplanted kidney

    Page :S10

    E. Volynchik, L. Bolshakov, M. Kaabak, N. Bogomolova, V. Goryainov, E. Balakirev, S. Kuznetsova

    
  • ·P01.02 Trends in anti-MRSA antibiotic use and the burden of MRSA in a network of 55 German ICUs, 2001–2009

    Page :S10

    E. Meyer, F. Schwab, B. Schroeren-Boersch, P. Gastmeier

    
  • ·P01.03 Point prevalence survey of antimicrobial prescriptions in Finnish nursing homes

    Page :S10

    M. Rummukainen, M. Kanerva, M. Haapasaari, T. Kärki, O. Lyytikäinen, B. Jans, A. Muller, H. Goossens

    
  • ·P01.04 Use of very old and very new antibiotics in intensive care units in 55 German ICUs, 2001–2009

    Page :S11

    E. Meyer, F. Schwab, B. Schroeren-Boersch, P. Gastmeier

    
  • ·P01.05 Current clinical use of daptomycin in Europe from the European Cubicin® Outcomes Registry and Experience (EU-CORE)

    Page :S11

    A. Gonzalez-Ruiz, P. Gargalianos-Kakolyris, Z. Dailiana, A. Cogo, V.J. González-Ramallo, P. Dohmen, M.C. Fariñas, A. Galloway, P. Nikolaidis, K. Bouylout, J. Loeffler, R.L. Chaves

    
  • ·P01.06 Daptomycin for outpatient parenteral antibiotic therapy (OPAT), a European registry experience

    Page :S11

    R.A. Seaton, V.J. González-Ramallo, V. Prisco, A. Galloway, K. Bouylout, R.L. Chaves

    
  • ·P01.07 Clinical experience with daptomycin from regional Lancashire cardiac centre in northwest England

    Page :S12

    M. Przybylo, A. Kumar, N. Waddington, A. Guleri

    
  • ·P01.08 A comparative study of antibiotic gradient devices for the determination of MIC for meropenem, ceftriaxone, clindamycin and teicoplanin

    Page :S12

    S. Reed, D. Crabtree

    
  • ·P01.09 ‘Alert stickers’ as prescribing aids to limit duration of antimicrobial treatment

    Page :S12

    C. Collins, K. Bradley, T. Moore, S. Foley, F. Fitzpatrick, E.G. Smyth

    
  • ·P01.10 Developing an antimicrobial management team within a department of medicine for the elderly

    Page :S12

    H. Cronin, Y. Lim, A. Foley, M. Siddiqi, R. Cooke

    
  • ·P01.11 Empiric therapy of urinary tract infections acquired in long term care institutes

    Page :S13

    C. Pirali, F. Pirali

    
  • ·P01.12 Audit of antimicrobial prescribing compliance with City Hospitals Sunderland policy for lower respiratory tract infections including influenza

    Page :S13

    B. Main

    
  • ·P01.13 Are antibiotics used appropriately on surgical wards?

    Page :S13

    R. Crosbie

    
  • ·P01.14 Antibiotic prophylaxis at caesarean section – guidelines and clinical practice – Norway

    Page :S14

    H.M. Eriksen, H.L. Løwer, F.E. Skjeldestad

    
  • ·P01.15 Improving the prescribing of antimicrobial medication in a secondary care mental health trust

    Page :S14

    N. Chilton, J. Hughes, L. Prescott

    

• Poster Session 2 – Blood Borne Viruses (HIV, Hep B, Hep C): Management and Prevention

  • ·P02.01 A pilot survey to identify barriers to the reporting and management of occupational exposures to blood borne viruses in healthcare workers

    Page :S14

    S. Winchester, S. Tomkins, M. Zuckerman, S. Cliffe, L. Batty, P. Grime, F. Ncube

    

• Poster Session 3 – Care Bundles and Care Pathways

  • ·P03.01 A multi-centre study of reliability in intravenous cannulation in hospital inpatients

    Page :S14

    V. Deelchand, M. Cooke, A. Holmes, B. Dean Franklin, S. Burnett

    

• Poster Session 4 – Clinical Cases

  • ·P04.01 ‘The 6 Million Dollar Man’: An unusual case of adaptative commensalism with multidrug resistant bacteria in a surgical patient treated for 18 months

    Page :S15

    M. Przybylo, S. Summers, A. Guleri, M. Qulaghassi

    
  • ·P04.02 A case of Mycobacterium fortuitum causing surgical site wound infection

    Page :S15

    F. Kaleem, J. Usman, K. Roz Uddin, M. Omair, A. Khalid, A. Hassan

    
  • ·P04.03 A case of isolation of an unusual pathogen from ascitic fluid

    Page :S15

    F. Kaleem, S. Abbasi, J. Usman, A. Hassan

    

• Poster Session 5 – Community Healthcare Infections

  • ·P05.01 Prevalence study of infections in a Mental Health Trust

    Page :S16

    J. Hughes, L. Rosbottom, L. Jennings

    
  • ·P05.02 Evaluation of Oxoid Contrast™ MRSA broth for the detection of MRSA

    Page :S16

    D. Crabtree

    
  • ·P05.03 High frequency of resistance to fluoroquinolones & cephalosporins in Gram negative bacteria in healthy neonates from community

    Page :S16

    R. Gaind, L.C. Singh, A. Sinha, M. Deb, S. Saxena

    
  • ·P05.04 Cluster of two patients with community-acquired MRSA arthritis in the eastern part of the Netherlands traced to a general practitioner

    Page :S17

    E. Mascini, M. Schouten, P. Cornelissen, T. Waegemaekers

    

• Poster Session 6 – Costs of Healthcare Associated Infections

  • ·P06.01 Direct costs of antibiotic treatment of hospital acquired infections in Polish hospitals

    Page :S17

    A. Rózańska, J. Wójkowska-Mach, M. Bulanda, P.B. Heczko

    
  • ·P06.02 Impact of healthcare-associated infections and antimicrobial use in intensive care

    Page :S17

    M.J. Nobre Oliveira

    
  • ·P06.03 MRSA PCR screening: is it still a cost effective option during times of financial turbulence in NHS hospitals?

    Page :S18

    A. Guleri, J. Carter-Lindsay, B. Lunt, R. Palmer, N. Harper

    
  • ·P06.04 Costs of antibiotics consumption in neonatal intensive care units in Poland

    Page :S18

    A. Rózańska, J. Wójkowska-Mach, P.B. Heczko

    
  • ·P06.05 A point prevalence study of healthcare-associated infection in patients with delayed discharge in an acute tertiary referral hospital

    Page :S18

    S. McNicholas, C. Andrews, K. Boland, M. Shields, G. Doherty, F. Murray, E.G. Smyth, H. Humphreys, F. Fitzpatrick

    

• Poster Session 7 – Device Related Infections

  • ·P07.01 Central line associated bloodstream infections in 2 Polish neonatology intensive care units: incidence, microbiology and antibiotic consumption

    Page :S18

    M. Brzychczy-Wloch, J. Wójkowska-Mach, A. Rózańska, E. Gulczynska, R. Lauterbach, P.B. Heczko

    
  • ·P07.02 Glutaraldehyde and other aldehyde resistant bacteria associated with the use of washer-disinfectors used in the reprocessing of flexible endoscopes

    Page :S19

    G. McDonnell, A. Fiorello, C. Fisher, D. Shaffer, Z. Svetlikova, M. Jackson

    
  • ·P07.03 Study of catheter related blood stream infections due to intravascular catheter colonization

    Page :S19

    D.L.B. Piyasiri, P. Chandrasiri, D.N.D. Dinarathnage, D.S. Gamage

    
  • ·P07.04 An evaluation of the antimicrobial efficacy of a chlorhexidine gel pad intravascular catheter dressing using a skin model

    Page :S19

    T.J. Karpanen, A.L. Casey, B.R. Conway, P.A. Lambert, T. Worthington, T.S.J. Elliott

    
  • ·P07.05 Reuse of a single-use sterile device: example of prefilled sterile humidifiers

    Page :S20

    L. Belotti, S. Lambert, B. Allaham, J. Foegle, C. Hernandez, S. Mechkour, C. Ménard, T. Lavigne

    
  • ·P07.06 Intravenous in-line filtration and infection risk, interpreting the CDC guidelines

    Page :S20

    P. Ball

    
  • ·P07.07 Surveillance of central venous catheter-associated bloodstream infections: incidence rate depending on the service where the CVC is inserted

    Page :S20

    H.R. Rolando, J. Barrenengoa-Sañudo, M.J. Molina-Gomez, A.C. Martin-Ruiz, P. Garcia-Shimizu, R. Camargo-Angeles, C. Villanueva-Ruiz, J. Sánchez-Payá

    
  • ·P07.08 The potential role of patient awareness in the prevention of peripheral catheter-related bloodstream infection

    Page :S21

    S. McHugh, M. Corrigan, B. Dimitrov, M. Morris-Downes, F. Fitzpatrick, S. Cowman, S. Tierney, A. Hill, H. Humphreys

    
  • ·P07.09 Quorum sensing accessory gene regulator (agr)-specificity groups in Staphylococcus epidermidis from prosthetic joint and catheter infections

    Page :S21

    L. Harris, E. Dudley, H. Rohde, D. Mack

    
  • ·P07.10 The development of a PCR method to investigate the efficacy of propidium monoazide to inhibit dead bacteria without impacting live bacteria

    Page :S21

    W. Ashraf, S. Bainbridge, R. Bayston

    
  • ·P07.11 How safe is colonoscope-reprocessing regarding Clostridium difficile spores?

    Page :S21

    M. Hell, C. Bernhofer, S. Huhulescu, A. Indra, F. Allerberger, M. Maass, E. Hakalehto

    
  • ·P07.12 Infection control in bone & joint surgery: do surgeons contribute in transmitting infections during operations?

    Page :S22

    R. Dahab, D. Gheorghiu, B. Husein, V. Peter

    

• Poster Session 8 – Decontamination

  • ·P08.01 The cleanability of different hospital bedrails

    Page :S22

    S. Ali, G. Moore, A.P.R. Wilson

    
  • ·P08.02 Hydrogen peroxide vapor (HPV) inactivation of feline calicivirus, a surrogate for norovirus

    Page :S22

    S. Goyal, Y. Chander, S. Yezli, J. Otter

    
  • ·P08.03 Antifungal activity of chemical agents against Candida albicans

    Page :S23

    A.P. Silva, S. Figueiredo, C. Lisboa, R. Rocha, C. Pina-Vaz, A.G. Rodrigues

    
  • ·P08.04 Hydrogen peroxide vapor (HPV) decontamination of an intensive care unit room used to treat a patient with Lassa fever

    Page :S23

    J. Otter, M. Barnicoat, J. Down, D. Smyth, S. Yezli, A. Jeanes

    
  • ·P08.05 Efficacy of a hydrogen peroxide dry-mist disinfection system for hospital environment disinfection

    Page :S23

    A.P. Silva, C. Pina-Vaz, A.G. Rodrigues, T. Carvalho

    
  • ·P08.06 Occult risk of healthcare associated infections by poor handling bedpans

    Page :S23

    G.V. Knippenberg-Gordebeke

    
  • ·P08.07 Contamination of a purified water system by Aspergillus fumigatus in a new endoscopy reprocessing unit

    Page :S24

    A. Smith, G. McCormack, A. Stewart, P. Morrison, D. Shaw, M. Peat, A. Mead, P. Howard

    
  • ·P08.08 An evaluation of the anti-sporicidal efficacy of disinfectants available to hospitals to reduce the viability of Clostridium difficile

    Page :S24

    S. Speight, J. Walker, R. Chitnis, P. Hoffman, A. Bennett

    
  • ·P08.09 Detection of the potential risks of transmission of HIV and hepatitis C virus during flexible endoscopy

    Page :S24

    T. Grenkova, E. Selkova, N. Nosik, D. Nosik, I. Kiseleva, P. Deryabin

    
  • ·P08.10 An evaluation of ECASOL-AQ™ to eradicate nosocomial pathogens from contaminated mattresses

    Page :S25

    A. Dolan, B. McEntee, E. Creamer, A. Shore, R. Cunney, D.J. Sullivan, R.J. Russell, D.C. Coleman, H. Humphreys

    
  • ·P08.11 Effect of long-term disinfection on common clinical contact surfaces

    Page :S25

    C.J. Palenik

    
  • ·P08.12 An investigation into the robustness of hydrogen peroxide electrochemical sensors for disinfection process control

    Page :S25

    D.J. Malik, K. Schou, G. Shama

    
  • ·P08.13 Comparative efficacy of high level disinfectants: in-hospital evaluation with manual or automatic endoscope reprocessors

    Page :S26

    B. Peláez, R. Andrade, M. Fuentes, I. Hernández, J. Fereres

    
  • ·P08.14 Disinfectants efficacy against hardy viruses dried onto surfaces

    Page :S26

    G. McDonnell, M. Eterpi, V. Thomas

    
  • ·P08.15 Decontamination of mycoplasma with gaseous hydrogen peroxide

    Page :S26

    G. McDonnell, M. Eterpi, V. Thomas

    
  • ·P08.16 A simple microbiological validation method for endoscope drying cabinets

    Page :S27

    R. Cooke, T. Kerry, V. Jackson, R. Sturgess

    
  • ·P08.17 Antimicrobial efficacy of novel Euclean® hard surface disinfectant wipes

    Page :S27

    E. Hendry, T. Worthington, B.R. Conway, P.A. Lambert

    
  • ·P08.18 Comparative evaluation of anaesthesia cleaning cycle performed in washer-disinfectors by visual inspection versus total protein quantification

    Page :S27

    V. Sebastián, R. Andrade, L. Barreales, B. Peláez, C. Fernández, J. Fereres

    
  • ·P08.19 Comparative evaluation of surgical cycle performed in washer-disinfectors by visual inspection versus total protein quantification

    Page :S27

    V. Sebastián, B. Peláez, L. Barreales, R. Andrade, C. Fernández, J. Fereres

    

• Poster Session 9 – Education and Training in Infection Control

  • ·P09.01 The differences in awareness of and procedures affecting the prevention of infectious disease among 3 different professions at nursing homes

    Page :S28

    A. Kudou, M. Ikeda, M. Aminaka, M. Yuasa, K. Nishina, T. Mino

    
  • ·P09.02 Infection prevention & control from student to senior: a whole team approach to education and development

    Page :S28

    S. Murdoch

    
  • ·P09.03 Nursing students intentions and patterns of adherence to uncommonly used standard precaution (SP) guidelines, a cohort study

    Page :S28

    I. Livshiz-Riven, O. Anson

    
  • ·P09.04 Challenging cleanliness champions – inspiration, information, instigation

    Page :S29

    K. Wares, J. Grant, A.N. Hendry, C. Mitchell

    
  • ·P09.06 A longitudinal study of hospital hand hygiene adherence

    Page :S29

    J. Randle, N. Vaughan

    
  • ·P09.08 An approach for establishing a link pharmacist system: toward active involvement of pharmacists in ensuring the appropriate use of antibiotics

    Page :S29

    K. Kimura, A. Yamagata, T. Tanaka, N. Shiraishi, Y. Shibuya

    
  • ·P09.09 The benefits and barriers to online learning for infection control education

    Page :S30

    M. Nevill, L. Palfreyman, A. Myers, J. Wade, P. Lohr

    
  • ·P09.10 Which PPE is right for you?

    Page :S30

    L. Lerner

    
  • ·P09.11 Comparative assessment of infection control training course between undergraduate medical students and internships physician: an Egyptian experience

    Page :S30

    N. Omar, M. El-Farrash, M. El Hadidy, R. Badre, M. El-Daker, G. Maghwary, E. Hamad, H. Askar, M. Mesbah, W. El Dars, D. Tawefek, D. Moemen

    
  • ·P09.12 Attitudes, awareness and knowledge of healthcare-associated infection among consultant surgeons in the Republic of Ireland

    Page :S30

    D. O’Brien, S. McHugh, A. Hill, H. Humphreys

    
  • ·P09.13 Development of a targeted e-learning programme for surgical infection prevention

    Page :S31

    S. McHugh, M. Corrigan, S. Cowman, S. Tierney, B. Dimitrov, A. Hill, H. Humphreys

    
  • ·P09.14 Developing local “champions” to lead on the management of health care infection (HAI) in clinical settings

    Page :S31

    A.N. Hendry

    
  • ·P09.15 Kowledge of healthcare students about prevention of nosocomial infection and standard precaution in Italy

    Page :S31

    F. Auxilia, D. D’Alessandro, L. Calligaris, A. Colosi, M. Ferrante, M.T. Montagna, I. Mura, C. Pasquarella, V. Pippia, E. Righi, A. Rossini, S. Tardivo

    
  • ·P09.16 Infection control champions: a randomized clinical trial

    Page :S31

    E. Lloyd-Smith, J. Curtin, M. Romney

    
  • ·P09.17 Implementation of an infection control champions project in a North American setting: feedback from focus groups

    Page :S32

    E. Lloyd-Smith, W. Gilbart, M. Romney

    

• Poster Session 10 – Emerging Pathogens and their Controls

  • ·P10.01 Comparison of the impact between antimicrobial optimization and implementation of infection control practice on emerging of resistant organisms

    Page :S32

    S. Hori, S. Kondo, Y. Uehara, K. Kikuchi

    
  • ·P10.02 Resistance of Chlamydia-like bacteria to disinfection and survival on surfaces

    Page :S32

    C. Coulon, A. Collignon, G. McDonnell, V. Thomas

    

• Poster Session 11 – Environmental Issues: Water, Air, Cleaning

  • ·P11.01 Resistance of Acanthamoeba spp. cysts to disinfection treatments

    Page :S33

    C. Coulon, A. Collignon, G. McDonnell, V. Thomas

    
  • ·P11.02 Ingress and egress of pathogens from single isolation rooms

    Page :S33

    M. Muzslay, G. Moore, A.P.R. Wilson

    
  • ·P11.03 Identifying opportunities to improve environmental hygiene in multiple healthcare venues

    Page :S33

    P. Carling, J. Po, J. Bartley, L. Herwalt

    
  • ·P11.04 Optimising the recovery of methicillin resistant Staphylococcus aureus from surfaces using direct contact plates

    Page :S33

    P. Wolyniec, D.J. Malik, G. Shama

    
  • ·P11.05 Cleanliness audit of clinical surfaces and equipment: who cleans what?

    Page :S34

    S.J. Dancer, R. Anderson, V. Young, M. Stewart

    
  • ·P11.06 Finding a benchmark for monitoring hospital cleanliness

    Page :S34

    S.J. Dancer, D. Mulvey, P. Redding, C. Robertson, C. Woodall

    
  • ·P11.07 An evaluation of the antimicrobial properties of healthcare fomites (furnishings and equipment) made of copper alloys

    Page :S34

    T.J. Karpanen, A.L. Casey, P.A. Lambert, B.D. Cookson, P. Nightingale, L. Miruszenko, T.S.J. Elliott

    
  • ·P11.08 The effect of a mobile air purification unit on the air quality of a room contaminated with Aspergillus sp.

    Page :S35

    P. De Waegemaeker, N. Bovyn, M. Vanneste, G. Verschraegen

    
  • ·P11.09 Water microfiltration at the point of use – a procedure to prevent infection/colonization with water borne pathogens in ICU patients?

    Page :S35

    M. Hell, C. Unterkoefler, M. Dollenz, B. Richling, C. Luger, H. Mittermayer, M. Maass

    
  • ·P11.10 A global approach for microbial environmental contamination study in dental clinic

    Page :S35

    C. Pasquarella, E. Capobianco, S. Pizzi, P. Vitali, F. Paganuzzi, L. Veronesi, M.L. Tanzi

    
  • ·P11.11 The effectiveness of a hospital environment maintenance aimed at the infection prevention against Pseudomonas aeruginosa in Japan

    Page :S35

    K. Imaizumi, Y. Sato, M. Igari, K. Ishii, M. Endo, K. Kan, Y. Teranishi, S. Hatae, M. Takagi, H. Miyamoto

    
  • ·P11.12 The effect of a novel air disinfection system on airborne microorganisms in a hospital outpatients clinic

    Page :S36

    D. O’Brien, N. Stevens, D. Fitzgerald-Hughes, H. Humphreys

    
  • ·P11.13 Comparison of microbial ecology and antibiotic resistance before and after routine cleaning in the intensive care unit

    Page :S36

    G. Kay, T. Smith, K. Stanley, D. Edbrooke, G. Mills, R. Townsend

    
  • ·P11.14 Microbial air monitoring in a bone marrow transplant unit: experience at the University Hospital in Parma

    Page :S36

    C. Pasquarella, R. Albertini, E. Saccani, M. Ugolotti, F. Mariotti, C. Boccuni, P. Manotti, P. Vitali, C. Signorelli, G.E. Sansebastiano

    
  • ·P11.15 Use of a dusting cloth for mycological surveillance of operating rooms: results of an Italian pilot study

    Page :S37

    D. D’Alessandro, I. Mura, M.T. Montagna, M. Fabiani, F. Cerquetani, C. Napoli, M.G. Deriu, N. Vescia

    
  • ·P11.16 Evaluation of three air decontamination devices as part of the smart solutions for healthcare associated infections programme

    Page :S37

    K. Williams, B. Griffiths, P. Bassett, C. Stapleton, E. James

    
  • ·P11.17 Improving endoscopy decontamination processes to minimise service disruption due to water test failures

    Page :S37

    L. Lines, P. Moncur

    
  • ·P11.18 Environmental surveillance strategy for the prevention and control of Legionellosis

    Page :S38

    M.J. Hernández-Navarrete, C. Lapresta-Moros, S. Pastor-Eixarch, F. Ledesma-Lardies, S. Belkebir, G. Santana-López

    
  • ·P11.19 The use of ATP bioluminescence assay as an educational tool to improve cleaning in ICU

    Page :S38

    E. Pina, E. Ferreira, B. Matos

    
  • ·P11.20 A two-year double cross-over study investigating point-of-use filters for reducing Gram-negative nosocomial pathogens from hospital water

    Page :S38

    C.L. Wright, L. Newton, K.G. Kerr, A.M. Snelling

    
  • ·P11.21 Particle measuring system and microbiological sampling: do we need both?

    Page :S38

    C. Lapresta-Moros, S. Belkebir, M.J. Hernández-Navarrete, J. Meléndez-Pérez, F. India-Liso, A. Rezusta-López, G. Santana-López

    
  • ·P11.22 Time trend of Legionella colonization in the waterline of a hospital of Rome, Italy

    Page :S39

    D. D’Alessandro, M. Fabiani, A. Vulcano, F. Cerquetani

    
  • ·P11.23 Effect of forced-air warming (FAW) on operating theatre air quality: assessment using computer modeling and submicron particle release

    Page :S39

    R. Olmsted, F. Memarzadeh, R. Kulpmann, B. Schlautmann

    
  • ·P11.24 Review of current evidence on the reduction of infection rates in ten NHS hospitals using the Inov8 AD (air disinfection) technology

    Page :S39

    A. Ezbiri, R. Elen, J. Leech

    
  • ·P11.26 The international forum for water hygiene in buildings: recommendations for water quality in healthcare premises

    Page :S40

    M. Exner, P. Hartemann, J. Lee, S. Lee, E. Lin, K. Nath, M. Ricci, A. Thouraya, M. Sabria, J. Stout, E. Calderon

    
  • ·P11.27 Perspectives from across the pond: lessons learned from design, construction & operation of ventilation systems to protect patients against HCAI

    Page :S40

    R. Olmsted

    
  • ·P11.28 Point of use water filters for haemato-oncology patients: do they have a measurable effect on nosocomial waterborne diseases?

    Page :S40

    M. Hell, C. Bernhofer, M. Maass, R. Greil

    

• Poster Session 12 – Fungal Infections

  • ·P12.01 Investigation of the value of monitoring serum galactomannan in the early diagnosis of invasive fungal infection in immunocompromised patients

    Page :S41

    A. Galloway

    
  • ·P12.02 Investigation of serum galactomannan in the early diagnosis of invasive fungal infection in immunocompromised patients during building work

    Page :S41

    N. Rennison, A. Galloway

    

• Poster Session 13 – Gastrointestinal Infections: Clostridium Difficile, Norovirus

  • ·P13.01 Susceptibility of Clostridium difficile to single and combinations of antimicrobials

    Page :S41

    P. Roberts, K. Antoniou, F. Miyajima, M. Little, G. Smith, M. Pirmohamed, C. Parry

    
  • ·P13.02 Treating Clostridium difficile: are we adhering to current antimicrobial guidelines based on severity of infection?

    Page :S41

    A. Hartopp, Y. Jamil, S. Kabadayi, J. Cooper

    
  • ·P13.03 Use of an algorithm for managing nosocomial outbreaks of diarrhoea and vomiting

    Page :S42

    S. Gossain, E. Smit, K. Hardy, I. Gupta

    
  • ·P13.04 Exploring the clinical utility of faecal biomarkers to investigate Clostridium difficile infection (CDI)

    Page :S42

    A. Swale, F. Miyajima, T. Farragher, P. Roberts, M. Little, N.J. Beeching, J. Anson, G. Smith, C. Parry, M. Pirmohamed

    
  • ·P13.05 ‘A distressing experience’: a study of the psycho-social aspects of Clostridium difficile infection

    Page :S42

    M. Przybylo, M. Qulaghassi, A. Guleri, J. Moon

    
  • ·P13.06 Germinate to exterminate: a novel way of eliminating Clostridium difficile spores

    Page :S43

    L. Wheeldon, T. Worthington, P.A. Lambert

    
  • ·P13.07 Low nosocomial transmission rate of C. difficile (CD) in a university hospital with high CD infection incidences

    Page :S43

    F. Mattner, I. Winterfeld, E. Kramme, M. Martin

    
  • ·P13.08 A comparison of the PCR-ribotype distribution of Clostridium difficile in primary care and hospital settings

    Page :S43

    K.V. Patel, M.R.J. Clokie, D.J. Malik, G. Shama

    
  • ·P13.09 Testing strategy for Clostridium difficile associated diarrhoea (CDAD)

    Page :S44

    R. Cunningham, M. Wallis, P. Jenks

    
  • ·P13.10 Norovirus outbreaks versus operational activity: a balancing act

    Page :S44

    J. Wyeth, N. Virgincar, A. Stacey, S. Chrisopoulos, C. Honor

    
  • ·P13.11 An audit into the use of immunoglobulin for the treatment of C. difficile infection in a district hospital

    Page :S44

    L. Henderson, R. Koerner

    
  • ·P13.12 Hospitalized patients 65 years old with WBC 12k/μL have increased risk of C. difficile related death within 1 month of diagnosis

    Page :S44

    L. Archbald-Pannone, P. Korpe, R. Fitzgerald, R. Guerrant

    
  • ·P13.13 Value of realtime monitoring of comprehensive Clostridium difficile infection containment programme [CCDP] and impact of rise in clindamycin usage (DDD)

    Page :S45

    A. Guleri, R. Palmer, N. Harper, K. Woodrow

    

• Poster Session 14 – Hand Hygiene

  • ·P14.01 Hand hygiene short intervention campaign impact

    Page :S45

    J. Rodíguez-García, Y. Garcés Catalán, M.J. Salaverri-Nalda, I. Rodríguez-García, R. Fernandez-Santos, R. López-Barrachina, V. Warona

    
  • ·P14.02 A multi-disciplinary team’s multi-modal strategy to increase hand hygiene compliance at a Toronto teaching hospital

    Page :S45

    M. Muller, N. Siddiqui

    
  • ·P14.03 The WHO five moments for hand hygiene: the frequency of failure to perform hand hygiene on leaving the patient area

    Page :S46

    G. FitzGerald, G. Moore, A. Jeanes, A.P.R. Wilson

    
  • ·P14.04 False hand hygiene with gloves only

    Page :S46

    I. Meriö-Hietaniemi, K. Hietaniemi

    
  • ·P14.05 Two reality TV series reveal the reality of hand hygiene compliance in two Finnish hospitals

    Page :S46

    A. Hintikka, K. Kainulainen, V. Anttila

    
  • ·P14.06 Healthcare workers’ hand hygiene compliance in Madrid region. Target and opportunities for intervention

    Page :S47

    P. Rodriguez Perez, M. Cantero Caballero, R. Pla Mestre, A.B. Jimenez Muñoz, J. Valdes, C. NavarroRoyo, À. Pardo Hernandez

    
  • ·P14.07 Two effective ways to improve hand hygiene compliance

    Page :S47

    M. Ikeda, S. Hori, M. Satou, K. Hiramatsu, H. Kobayashi

    
  • ·P14.08 Hand hygiene; cracking the code, one step forward

    Page :S47

    T. Thomas, J. Walsh, C. Finn, F. Duffy, F. McCormack

    
  • ·P14.09 Five-year results of a program to improve hand hygiene

    Page :S47

    R. Camargo-Angeles, P. Garcia-Shimizu, C. García-González, M. Fuster-Pérez, A.C. Martin-Ruiz, M.J. Molina-Gomez, H.R. Martínez, J. Sánchez-Payá

    
  • ·P14.10 Knowledge gap as potential barrier to hand hygiene compliance

    Page :S48

    L. Lawlor, J. Ptak, J. Puffer, K. Kirkland

    
  • ·P14.11 An audit on hand washing practice among healthcare workers at national hospital of Sri Lanka

    Page :S48

    W.M.D.K. Dasanayake, P. Chandrasiri

    
  • ·P14.12 Skin evaluations of a novel alcohol-based hand rub, MR06B7

    Page :S48

    T. Miura, H. Nagahara, J. Okunishi, M. Seto, M. Ikeda

    
  • ·P14.13 In vitro and in vivo evaluations of a novel alcohol-based hand rub, MR09B13

    Page :S49

    J. Okunishi, T. Miura, T. Yagi, H. Nagahara, K. Tsujitani, H. Matsuse, Y. Nishihara, M. Seto, M. Ikeda

    
  • ·P14.14 Hand hygiene for hemodialysis treatments: optimizing the workflow is the solution to improve hand hygiene compliance

    Page :S49

    S. Scheithauer, J. Mankartz, F. Eitner, H. Haefner, K. Nowicki, J. Floege, S. Lemmen

    
  • ·P14.15 Effectiveness of an intervention to improve the compliance of hand hygiene recommendations at hospital setting

    Page :S49

    M. Fuentes, R. Andrade, B. Peláez, L. Barreales, N. Del Prado, S. Cano, J. Fereres

    
  • ·P14.17 Does systematic feedback on use of alcohol hand rub and soap affect healthcare-associated infections in hospitals? A controlled intervention study

    Page :S50

    T. Herud, R.M. Nilsen, K. Svendheim, P.E. Akselsen, H. Ersland, S. Harthug

    
  • ·P14.18 Determinants of hand hygiene compliance: physicians and nurses are not the same

    Page :S50

    V. Erasmus, J.H. Richardus, P. van Empelen, A. Oenema, E.W. Steyerberg, M.C. Vos

    
  • ·P14.19 Contamination of non-sterile gloves by Bacillus cereus and non-spore forming bacteria

    Page :S50

    K. Beesemans, A. Van Thielen, V. Cossey, A. Jeurissen, A. Schuermans

    
  • ·P14.20 Direct observation of hand hygiene in a teaching hospital

    Page :S51

    M. Rosales, M.A. Fernandez, O. Muñoz, G. Roca, M. Skodova, P. Garcia, M. Porta

    

• Poster Session 15 – Immunisation

  • ·P15.01 A toolkit to facilitate rapid immunisation and education of hospital staff during influenza outbreaks

    Page :S51

    S. Redfern, S. Marshall, E. Railton, E. Youlton, R. Vivancos, G. Thomson, N.J. Beeching

    
  • ·P15.02 Influenza vaccination coverage among healthcare workers and determinants of vaccination during the 2009–2010 season

    Page :S51

    C. Villanueva-Ruiz, J. Sánchez-Payá, L. Cartagena-Llopis, J. Barrenengoa-Sañudo, R. Camargo-Angeles, H.R. Martínez, Mª. González-Hernández, A. Rincon

    

• Poster Session 16 – Infection Control in the Developing World

  • ·P16.01 Role of prevalence survey for monitoring emerging trends in hospital acquired infections (HAI)

    Page :S52

    R. Gaind, M. Deb

    
  • ·P16.02 Monitoring of intrahospital infections in the General Hospital Uzice

    Page :S52

    S. Pavic, S. Andric, O. Vucicevic, M. Jovanovic

    
  • ·P16.03 An audit on vascular access devices at National Hospital of Sri Lanka

    Page :S52

    S. Welikumbura

    

• Poster Session 17 – Infection Control, Policies and Procedures

  • ·P17.01 Behind closed doors – improving practice of transmission based precautions through sustained education, auditing & feedback

    Page :S52

    J. Walsh, C. Finn, F. Duffy, F. McCormack, T. Thomas

    
  • ·P17.02 An outbreak Of Staphylococcus aureus after thoracoscopy

    Page :S53

    Y. Hendriks, H. Coertjens, M. v. Rijen, J. Kluytmans

    
  • ·P17.03 Infection control measures taken during lumbar punctures: a survey of current practice

    Page :S53

    S. Kelly, R. Malhotra

    
  • ·P17.04 Universal admission screening as the next successful step in a MRSA containment strategy

    Page :S53

    E. Nulens, S. Pinxten, B. Heyneman, A. Lenez, B. Gordts

    
  • ·P17.05 An approach for establishing a link pharmacist system: toward active involvement of pharmacists in ensuring the appropriate use of antibiotics

    Page :S54

    K. Kimura, A. Yamagata, T. Tanaka, N. Shiraishi, Y. Shibuya

    
  • ·P17.06 Isolation facilities for healthcare premises – the new guidance

    Page :S54

    M. Thomas

    
  • ·P17.07 Nasal swabs alone are inadequate for optimum detection of meticillin-resistant Staphylococcus aureus colonisation using the GeneOhm MRSA assay

    Page :S54

    K. Williams, E. James

    
  • ·P17.08 On the infection control for visit beauty & barber in healthcare centers – situation in Japan and future improvement

    Page :S54

    Y. Hiroki, H. Kuroda, N. Fujita, I. Murayama, M. Kanazawa, H. Yura, M. Takemoto, T. Ichikawa, K. Kan, H. Miyamoto, M. Igari, M. Takagi, Y. Hasegawa, S. Hatae

    
  • ·P17.09 Patient perceptions of doctors’ attire: how ‘bare below the elbows’ has impacted on the doctor-patient relationship

    Page :S55

    S. Jassim, B. Ollivere, A. Getgood, G. Tytherleigh-Strong

    
  • ·P17.10 Steps in strategic planning, designing and implementation of “hospital infection control manual” of a tertiary care institute of India

    Page :S55

    R.K. Sharma, P. Bhatia, A.K. Gupta

    
  • ·P17.11 Effects on the use of specific anti-microbial drugs and the rate of drug-resistant of organism following the introduction of notification system

    Page :S55

    M. Igari, M. Takagi, K. Imaizumi, Y. Sato, M. Endo, K. Ishii, K. Nagaoka, H. Miyamoto, K. Kan, Y. Teranishi, K. Watanabe, S. Hatae

    
  • ·P17.12 Consistency of MRSA screening

    Page :S56

    B. Kotnik-Kevorkijan, S. Lorenèiè-Robnik, M. Klasinc

    
  • ·P17.13 Follow up of MRSA positive elective surgical patients identified by pre-admission screening – the perils of assuming your colleagues’ knowledge base

    Page :S56

    A.P. Claxton, V. Longstaff

    
  • ·P17.14 Evaluation of the implementation of a change in isolation precautions for extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E)

    Page :S56

    H. Jansens, E. Goovaerts, F. Van Laer

    
  • ·P17.15 The point prevalence study of MRSA colonization in long-term-care facilities in the elderly acute care population in Krakow, Poland

    Page :S56

    M. Pobiega, R. Romaniszyn, J. Wójkowska-Mach, B. Gryglewska, T. Grodzicki, P.B. Heczko

    
  • ·P17.16 Isolation of patients with multiresistant Gram-negative rods: a new strategy

    Page :S57

    M. Vanneste, P. De Waegemaeker, N. Bovyn, G. Verschraegen, G. Claeys

    

• Poster Session 18 – Infections in High Risk Units (ICU, BMT etc)

  • ·P18.01 No etiological role of Klebsiella pneumoniae in a cluster of necrotizing enterocolitis in a neonatal intensive care unit

    Page :S57

    N. Verbraeken, I. Wybo, L. Blommaert, O. Soetens, F. Scheutz, C. Struve, A. Bougatef, D. Piérard

    
  • ·P18.02 Effectiveness and efficiency of current cleaning protocols on Adenovirus in the environment – 5 years data analysis in a UK children’s hospital

    Page :S57

    E. Cloutman-Green, J. Hartley

    
  • ·P18.03 Impact of 2% chlorhexidine gluconate impregnated wash cloths on vancomycin resistant Enterococci acquisition in high risk patients in Australia

    Page :S58

    P. Bass, D. Rhodes, K. Watson, D. Spelman, J. Kennon, A.C. Cheng, G. Land, R. Kehoe, G. Harrington

    
  • ·P18.04 Effectiveness of routine cleansing of patients with chloorhexidine gluconate 2% wipes for containment of drug resistant organisms in a medical ICU

    Page :S58

    A. Lenez, B. Gordts, M. Bourgeois, B. Oosterlynck, B. Deblauwe, B. Heyneman

    
  • ·P18.05 Serological screening of solid organ transplant donors in Ireland

    Page :S58

    A.F. Talento, D. Hickey, D. O’Neill, M. Keogan, F. Fitzpatrick, H. Humphreys, E.G. Smyth

    
  • ·P18.07 Isolation and identification of Candida species from the ward environment of an intensive care unit

    Page :S59

    G. Kay, A. Cabry, T. Smith, K. Stanley

    

• Poster Session 19 – Information Technology

  • ·P19.01 Virtual outbreak management

    Page :S59

    I. Gupta, D. Tomlinson, P. Birdi, K. Hardy

    
  • ·P19.02 Reviewing internet resources about prevention and risk management of hospital infections in Italy

    Page :S59

    I. Agreiter, L. Pagani, P. Mian

    
  • ·P19.03 E-dashboards & reporting: mechanisms for collation and feedback of infection control compliance data within the Southern Trust

    Page :S60

    S. Wallace

    

• Poster Session 20 – Investigation and Control of Outbreaks

  • ·P20.01 Epidemiology of an outbreak of MRSA in NICU, Qatar

    Page :S60

    J. Alajmi, M. Alishaq, M. Elsheikh

    
  • ·P20.02 Use of a timeline in the investigation of an outbreak of MRSA on an acute medical ward

    Page :S60

    O. Tkachenko, M. Khalifa, L. Fitzgibbon, A. Thompson, G.J. Hughes, N.M. Brown

    
  • ·P20.03 A cluster of invasive Candidiasis in neurosurgical intensive care unit patients – outbreak or pseudo-outbreak?

    Page :S60

    M. Hell, C. Unterkoefler, M. Dollenz, B. Richling, M. Maass, K. Grif, C. Lass-Floerl

    
  • ·P20.04 Crusted scabies – lessons from a recent outbreak

    Page :S61

    D. Harvey, A. Foley, R. Cooke

    
  • ·P20.05 An outbreak of nosocomial pseudomonas fluorescens due to contaminated drinking water in a bone marrow transplant unit

    Page :S61

    V. Wong, K. Levi, B. Baddal, J. Turton, T.C. Boswell

    
  • ·P20.06 Factors affecting prevention and control of viral gastroenteritis outbreaks in care homes

    Page :S61

    R. Vivancos, A. Oyinloye, A. Keenan

    
  • ·P20.07 Investigation and control of an outbreak with CTX-M-15-producing E. coli of sequence types 131 and 1441 in a neonatal surgical ward

    Page :S62

    C. Ahren, M. Andersson, M. Forsell, L. Helldahl, N. Karami, L. Larsson, E. Moore, C. Welinder-Olsson

    

• Poster Session 21 – Laboratory Issues: Diagnostics, Typing, New Technologies

  • ·P21.01 Clostridium difficile diagnosis in the East of England – A re-audit of laboratory methods

    Page :S62

    S. Pai, N.M. Brown

    
  • ·P21.02 Detection of ESBL, MBL and AmpC in Enterobacteriaceae and Acinetobacter spp. using Cica Beta tests in a routine diagnostic laboratory

    Page :S62

    W. Jamal, M. Shahin, V. Rotimi

    
  • ·P21.04 Comparison of the analytical sensitivity of three commercial real time PCR assays for the detection of MRSA

    Page :S63

    C. Pope, K. Capaldi

    
  • ·P21.05 Two step algorithm for the detection of Clostridium difficile from stool samples

    Page :S63

    N. Clark, M. Doughton, A. Karas, D. Enoch

    
  • ·P21.06 A United Kingdom audit of the laboratory diagnosis of Clostridium difficile infection

    Page :S63

    R. Cooke, A. Galloway, A. Collins, D. Holland, G. Trigg

    
  • ·P21.07 Evaluation of the application of the Scottish Clostridium difficile infection (CDI) testing protocol in a diagnostic laboratory

    Page :S63

    J. Coia, A. Leanord, W. Cowan, A. Badriya, G. McLean, D. Nelson, C. Wiuff, B. Adawi

    
  • ·P21.08 Novel applications of ATP bioluminescence for specific rapid microbial detection

    Page :S64

    M. Easter, P. Meighan

    

• Poster Session 22 – Operating Theatres

  • ·P22.01 Validity of preventive measures against needlestick injuries in the operating theatre

    Page :S64

    S. Koyama, Y. Momoi, T. Wakayama, Y. Shibuya

    
  • ·P22.02 Estimating operating room ventilation system performance in realistic scenarios

    Page :S64

    W. Zoon, J. Hensen, P. Zuurbier, J. Treur, M. Loomans

    

• Poster Session 23 – Outbreaks

  • ·P23.01 Rubella outbreak in a tertiary care Indian hospital: implications for immunisation policy

    Page :S65

    M. Singh

    
  • ·P23.02 The effect of household transmission on outbreaks of viral gastroenteritis in educational settings

    Page :S65

    R. Vivancos, C. Theodore, A. England, A. Keenan

    
  • ·P23.03 Appropriate management of a Clostridium difficile ribotype 027 outbreak has long term effects in reducing Clostridium difficile associated diarrhoea

    Page :S65

    M. Cotter, F. Fitzpatrick, H. Humphreys, T. Thomas, J. Walshe, J. Moore, M. Morris-Downes, E.G. Smyth

    
  • ·P23.04 A hospital acquired outbreak of Bacillus cereus gastroenteritis in a tertiary care hospital in Oman

    Page :S65

    S. Al-Abri, A. Al-Jardani, M. Al-Hosni, K. Padmamohan, S. Al-Busaidi, N.J. Beeching

    
  • ·P23.05 Out break of Proteus mirabilis in neonatal unit – lessons learnt

    Page :S66

    R. Gaind, B. Paglietti, R. Sehgal, S. Rubino

    
  • ·P23.06 Catheter-related bloodstream infections due to Ralstonia pickettii in patients undergoing hemodialysis

    Page :S66

    R. Cocconi, D. Montanaro, M. Messa, A. Mortal, C. Scarparo, A. Arzese, R. Fabro, A. Faruzzo, D. Tignonsini, L. Pagani, A. Moccia, S. Brusaferro

    
  • ·P23.07 Interdisciplinary approach to controling outbreaks

    Page :S66

    L. Lerner

    
  • ·P23.08 Outbreak of A. baumannii carbapenems resistant in the intensive care unit

    Page :S66

    M. Rosales, M.A. Fernandez, M.A. Jiminez, M. Skodova

    
  • ·P23.09 Description of an MRSA outbreak in a neonatal care unit in southern Sweden; emphasizing the importance of regular screen cultures

    Page :S67

    C. Karlsson, L. Nilsson

    
  • ·P23.10 VRE in a French teaching hospital: facing the tide?

    Page :S67

    C. Hernandez, C. Ménard, B. Jaulhac, J. Foegle, L. Belotti, D. Christmann, T. Lavigne

    

• Poster Session 24 – Resistant Gram Negative Bacterial Infection

  • ·P24.01 Patients with multiple multiresistant pathogens (MRSA, VRE, ESBL)

    Page :S67

    E. Meyer, R. Ziegler, F. Mattner, F. Schwab, M. Martin

    
  • ·P24.02 Regional variation in the prevalence of extended-spectrum β-lactamases in clinical isolates ofEnterobacter and Citrobacter species in Japan

    Page :S68

    H. Kanamori, H. Yano, Y. Hirakata, M. Ogawa, M. Shimojima, S. Endo, K. Arai, T. Aoyagi, N. Ishibashi, M. Hatta, M. Yamada, K. Nishimaki, Y. Takayama, H. Kunishima, M. Kitagawa, M. Kaku

    
  • ·P24.03 ESBL active surveillance culture in patients rehospitalized from other facilities and nursing homes

    Page :S68

    H. Kunishima, J. Chiba, M. Hatta, K. Nishimaki, M. Yamada, M. Kitagawa, H. Yano, Y. Hirakata, Y. Honda, M. Kaku

    
  • ·P24.04 Time trends and associated factors to antimicrobial resistance of Klebsiella pneumoniae infections in hospitalized patients. Spain 1999–2009

    Page :S68

    A. Asensio, T. Alvarez-Espejo, J. Sánchez-Payá, A. Ramos, E. Muñez, V. Dominguez, V. Pastor, J. Vaqué

    
  • ·P24.05 Time trends and associated factors to antimicrobial resistance of Escherichia coli infections in hospitalized patients. Spain, 1999–2009

    Page :S69

    A. Asensio, T. Alvarez-Espejo, R. Cantón, A. Ramos, E. Muñez, J. Molina, D. Monge, J. Vaqué

    
  • ·P24.06 Prevalence of highly resistant Enterobacteriaceae including ESBLs in retail meat

    Page :S69

    J. Bruin, M. van der Aar, I. Overdevest, J. Kluytmans, B. Diederen

    
  • ·P24.07 Time trends and associated factors to antimicrobial resistance of Acinetobacter baumannii infections in hospitalized patients. Spain, 1999–2009

    Page :S69

    T. Alvarez-Espejo, A. Ramos, R. Cantón, J. Vaqué, P. Rodriguez, F. Calbo-Torrecillas, V. Pastor, A. Asensio

    
  • ·P24.08 Time trends and associated factors to antimicrobial resistance of Pseudomonas aeruginosa infections in hospitalized patients. Spain, 1999–2009

    Page :S70

    T. Alvarez-Espejo, J. Vaqué, A. Ramos, E. Muñez, D. Monge, C. Bishopberger, V. Pastor, A. Asensio

    
  • ·P24.09 Study of beta-lactamases in clinical Acinetobacter isolates from Tehran, Iran

    Page :S70

    F. Shahcheraghi, M. Abbasalipour, N. Akbari, V.S. Nikbin, G.H. Ebrahimipour

    
  • ·P24.10 Molecular detection of TEM and AmpC (Dha and Mox)-type β-lactamase in clinical isolates of Escherichia coli

    Page :S70

    H. Molla Agha Mirzaei, M. Soltan Dallal, J. Fallah Mehrabadi, A. Sabbaghi, M. Hanafi Abdar

    
  • ·P24.11 Treatment options for multidrug-resistant Acinetobacter baumannii infections in a surgical intensive care unit

    Page :S70

    M.J. Oliveira, P. Almeida

    
  • ·P24.12 Is tigecycline a solution for metallo-β-lactamase producing multidrug resistant Gram negative bacilli?

    Page :S71

    F. Kaleem, J. Usman, A. Hassan

    
  • ·P24.13 Circulation of Enterobacteriaceae producing beta-lactamases in Italian long term care facilities (LTCFs)

    Page :S71

    L. Arnoldo, L. Regattin, R. Migliavacca, A. Goglio, L. Pagani, S. Brusaferro

    
  • ·P24.14 ESBL study in Peterborough; clinical & molecular epidemiology

    Page :S71

    D. Enoch, F. Brown, A. Sismey, D. Mlangeni, D. Cone, M. Curran

    
  • ·P24.15 Prevalence of ESBL production in Enterobacter, Serratia, Citrobacter and Morganella clinical isolates in 3 teaching hospitals in The Netherlands

    Page :S72

    B. Diederen, M. van der Aar, J. Cohen Stuart

    
  • ·P24.16 A parallel increase of ESBL producing Enterobacteriaceae in the hospital and outpatient setting in the Haarlem region, The Netherlands

    Page :S72

    C. Malipaard, E. Yzerman, M. van der Aar, S. Euser, B. Diederen

    
  • ·P24.17 Ertapenem resistant Klebsiella pneumoniae acquisition risk factors among hospitalized patients

    Page :S72

    G.B. Orsi, A. Carattoli, A. Giordano, A. Garcia-Fernandez, A. Bencardino, R. Gianfreda, M. Venditti

    
  • ·P24.18 Risk factors associated with resistance to 3rd gen cephalosporins in Enterobacteriaceae isolates from intensive care unit patients in Saudi Arabia

    Page :S73

    D. Baxter, N. Al-Abdullah

    

• Poster Session 25 – Resistant Gram Positive Bacterial Infection

  • ·P25.01 Methicillin-resistant Staphilococcus Aureus infections in a service of vascular surgery: evaluation of a prevention strategy

    Page :S73

    V. García-Roman, J. Sánchez-Payá, R. Camargo-Angeles, C. Villanueva-Ruiz, C. García-González, M. Fuster-Pérez, C. Escriva-Pons, J. Barrenengoa-Sañudo

    
  • ·P25.02 Are there regional differences in the burden of MRSA, VRE and ESBL in 219 German intensive care units, 2008–2009?

    Page :S73

    F. Schwab, E. Meyer, C. Geffers, P. Gastmeier

    
  • ·P25.03 Bed occupancy and methicillin-resistant Staphylococcus aureus infection rate in intensive care units: 2003–2008

    Page :S73

    M.J. Hernández-Navarrete, D. Bordonaba-Bosque, C. Lapresta-Moros, G. Santana-López, S. Belkebir, S. Pastor-Eixarch

    
  • ·P25.04 Difference of clonality between HLGR E. faecium and E. faecalis species isolated from clinical specimens in Tehran

    Page :S74

    N. Dadfarma, P. Farrokh, V.S. Nikbin

    
  • ·P25.05 Clinical pathology and control of community-acquired infection with methicillin-resistant Staphylococcus aureus in a Japanese emergency hospital

    Page :S74

    Y. Shibuya, M. Murakami, Y. Ogawa, Y. Momoi, A. Yamagata, K. Kimura, S. Koyama

    
  • ·P25.06 Antimicrobial susceptibility patterns of clinical isolates of methicillin resistant Staphylococcus aureus in Tehran hospitals, Iran

    Page :S74

    E. Javan, M. Saifi, G.H. Ebrahimipour, M. Shafiee, M.R. Pourshafie

    

• Poster Session 28 – Surgical Site Infections

  • ·P28.01 Local surveillance coordinator improves compliance of caesarean section surgical site infection surveillance

    Page :S75

    S.N. Henning, D. Garfield, F. Hughes, G. McIlvenny, G. Reid, H.E. Crookshanks, L. Doherty, E.T.M. Smyth

    
  • ·P28.02 Did observation and feedback of cardiothoracic surgical site infection improve infection rates?

    Page :S75

    M. Richards, S. Mcilduff, K. Williams, L. Hobbs

    
  • ·P28.03 Dealing with MRSA decolonisation failures and cancelled surgeries during NHS financial turbulence: a clinico-economic modelling study

    Page :S75

    S. Aggarwal, J. Tipping, B. McAlea, A. Guleri

    
  • ·P28.04 Surgical site infections after thoracic procedures

    Page :S76

    G. Gailiene, A. Stelioniene

    
  • ·P28.05 Surgical site infection (SSI) rates in robotic and laparoscopic colorectal surgery: a retrospective, case-control study

    Page :S76

    T. Law, N. Kenefick, S. Hoque

    
  • ·P28.06 The effect of hospital volume on surgical site infection rates following orthopeadic procedures: what seems to be the most appropriate threshold?

    Page :S76

    D. Weitzel-Kage, D. Sohr, M. Behnke, G. Petra

    
  • ·P28.07 Surgical site infection rate: surgeons’ perception vs reality

    Page :S76

    S. Vallabhajousula, I. Gunn, S. Cole

    
  • ·P28.08 Can a pre-operative checklist ensure best practice in surgical prophylaxis administration?

    Page :S77

    S. McHugh, M. Corrigan, S. Cowman, S. Tierney, P. Broe, A. Hill, H. Humphreys

    
  • ·P28.09 Surveillance of caesarean section surgical site infections to determine the extent of the problem and identify targets for intervention

    Page :S77

    N. Virgincar, B. Rafanan, C. Wloch, J. Wilson, A. Stacey

    
  • ·P28.10 Bacteriocholia in dynamics in patients with purulent cholangitis after different methods of external drainage of the common bile duct

    Page :S77

    Y.N. Maslov, A.I. Ershova, A. Popov, N. Sharybina

    
  • ·P28.11 Post discharge surveillance following caesarean section: incidence of surgical site infection

    Page :S78

    E. Morelli, G. McIlvenny, G. Reid, H.E. Crookshanks, L. Doherty, E.T.M. Smyth

    
  • ·P28.12 How accurate is orthopaedic surgical site surveillance? Experiences from a district general hospital

    Page :S78

    O. Donaldson, M. Cronin, R. Yate

    
  • ·P28.13 Duration cut points in orthopaedic surgery in Northern Ireland

    Page :S78

    G. Reid, G. McIlvenny, G. McAlinden, C. Andrews, B. Mockford, H.E. Crookshanks, L. Doherty, M. Godfrey, E.T.M. Smyth

    

• Poster Session 29 – Surveillance and Epidemiology of Healthcare Associated Infections

  • ·P29.01 Prospective dialysis surveillance and recommendations for its continuance in a major teaching hospital

    Page :S79

    R. Bajwa, A. Casey, P. Conlon, F. Fitzpatrick

    
  • ·P29.02 Audit of compliance with city hospitals Sunderland (CHS) guidelines for the use of urinary catheters and any associated infection rate and management

    Page :S79

    S. Main

    
  • ·P29.03 Mupirocin resistance in MRSA: local incidence and impact on decolonisation

    Page :S79

    C. Chu, M. Cullen

    
  • ·P29.04 A one-year retrospective study of community-acquired Gram negative bacteraemia in patients admitted to a district general hospital

    Page :S79

    E. Trainor, J.A. Bowley, C.M. Jukka, M.A. Kiernan, R. Gupta

    
  • ·P29.05 National surveillance of surgical site infections after coronary artery bypass grafting in Norway: incidence and risk factors

    Page :S80

    T.C. Berg, N.K. Sorknes, K.E. Kjørstad, P.E. Akselsen, B.E. Seim, M.N. Stenvik, H.L. Løwer, H.M. Eriksen

    
  • ·P29.06 Independent sector HCAI surveillance: comparability with data from NHS acute Trusts

    Page :S80

    J. Abernethy, R. Guy, M. Murray

    
  • ·P29.07 Laboratory diagnosis and typing of Clostridium difficile in the Republic of Ireland: an updated survey of Irish hospitals

    Page :S80

    F. Fitzpatrick, H. Byrne, F. Roche, S. Donlon

    
  • ·P29.08 Clostridium difficile asymptomatic carriage; look beyond the burden of new cases!

    Page :S81

    T. Thomas, J. Walsh, C. Finn, F. Duffy, F. McCormack, M. Downes, E. Smith, F. Fitzpatrick, H. Humphreys

    
  • ·P29.09 Scotland’s contribution to the European care home HALT survey

    Page :S81

    A. Mullings, F. Murdoch, J. Reilly

    
  • ·P29.10 Compliance of isolation precautions in a tertiary hospital

    Page :S81

    J. López-Contreras, M.L. Galvez, A. Cotura, V. Pomar, A.P. Cortes, N. Benito, M. Gurgui

    
  • ·P29.11 Enhanced surveillance of Clostridium difficile infection

    Page :S82

    I. Thompson, M. Hanrahan

    
  • ·P29.12 Can numbers of Staphylococcus aureus bacteraemias and Clostridium difficile be reduced in the absence of targets?

    Page :S82

    M. Morgan, S. Harris, V. McClure, E. Davies

    
  • ·P29.13 Effect of a national control program on the proportions of MRSA infections contributed by specific ward types in a us veterans affairs medical center

    Page :S82

    J. Thurn, T. Jacobson, K. Crossley

    
  • ·P29.14 An integrated approach for appraisal the role of microbial air contamination and antibiotic prophylaxis in hip and knee arthroprosthesis surgery

    Page :S82

    A. Agodi, F. Auxilia, M. Barchitta, D. D’Alessandro, I. Mura, C. Pasquarella

    
  • ·P29.15 Surveillance of nosocomial bloodstream infections and pneumonia in patients with hematopoetic cell transplantation (‘ONKO-KISS’)

    Page :S83

    M. Dettenkofer, M. Martin, D. Luft, R. Babikir, H. Bertz, A.F. Widmer, W.V. Kern, P. Gastmeier

    
  • ·P29.16 Methicillin-resistant Staphylococcus aureus in hospitals and the community: can screening interrupt the feedback loop?

    Page :S83

    S.R. Deeny, B.S. Cooper, B.D. Cookson, J.V. Robotham

    
  • ·P29.17 Reduction in C. difficile cases at a district hospital following interventions based on a care bundle approach

    Page :S83

    D. Enoch, A. Jack, D. Mlangeni, A. Sismey

    
  • ·P29.18 Universal screening for methicillin-resistant Staphylococcus aureus (MRSA) in an acute hospital

    Page :S84

    E. Creamer, A. Dolan, O. Sherlock, D. Fitzgerald-Hughes, T. Thomas, J. Walsh, A.C. Shore, D.J. Sullivan, P.M. Kinnevey, A.S. Rossney, P. O’Lorcain, E.G. Smyth, R. Cunney, D.C. Coleman, H. Humphreys

    
  • ·P29.19 MRSA bacteraemia in a district hospital with low levels of MRSA infection: lessons learnt and actions implemented as a result of root cause analysis

    Page :S84

    D. Enoch, N. Carter, J. Cargill, C. Wilkinson

    
  • ·P29.20 Epidemiology of methicillin resistant Staphylococcus aureus in Scotland

    Page :S84

    J. Wilson, A. Eastaway, G. Edwards, B. Cosgrove

    
  • ·P29.21 An evaluation of the installation and use of infection prevention surveillance software in a UK hospital environment

    Page :S85

    D. Simpson

    
  • ·P29.22 Use of national surveillance data to monitor possible unintended consequences of actions taken to reduce the rate of Clostridium difficile infection

    Page :S85

    A. Eastaway, G. Edwards, J. Wilson, C. Wiuff, A. Banks, W. Malcolm

    
  • ·P29.23 Nine years of SARI (surveillance of antimicrobial use and antimicrobial resistance in German intensive care units); 2001–2009

    Page :S85

    E. Meyer, F. Schwab, B. Schroeren-Boersch, P. Gastmeier

    
  • ·P29.24 The value of nasal swabs, multiple body site screening and clinical risk assessment to detect MRSA colonisation in pathfinder hospitals in Scotland

    Page :S86

    A. Smith, E. van Velzen, P. Christie, T. Stari, I. Gould, R. Masterton, J. Reilly

    
  • ·P29.25 Development of a clinical risk assessment tool to predict MRSA colonisation on admission to hospital

    Page :S86

    A. Smith, E. van Velzen, P. Christie, I. Gould, R. Masterton, J. Reilly, T. Stari

    
  • ·P29.26 Capturing the true incidence of Staphylococcus aureus bacteraemia

    Page :S86

    B. Mitchell

    
  • ·P29.28 Italian regional prevention program of healthcare associated infections. Model of intervention and use of performance indicators

    Page :S86

    P.A. Argentero, A. Castella, G. Mutu, C.M. Zotti

    
  • ·P29.29 Prevalence and risk factor analysis for vancomycin resistant Enterococci in renal dialysis patients: India

    Page :S87

    N. Taneja, M. Singh, V. Sakhuja, G. Sangar, G. Singh, M. Sharma

    
  • ·P29.30 The epidemiology of S. aureus bacteraemia: the value of local surveillance

    Page :S87

    A.K. Morris

    
  • ·P29.31 Assessment of the burden of healthcare-associated infections caused by selected antibiotic-resistant bacteria, Finland, 2008

    Page :S87

    M. Kanerva, J. Ollgren, O. Lyytikäinen

    
  • ·P29.32 Can we rely on biochemistry as a predictor for bacteraemia?

    Page :S88

    R.A. Leth, B.E. Forman, B. Kristensen

    
  • ·P29.33 MSSA blood stream infection – MRSA’s evil twin!: a review of the epidemiology, risk factors and outcomes among hospitalised patients with MSSA/MRSA BSI

    Page :S88

    M. Przybylo, M. Lau, M. Qulaghassi, A. Khan, J. Chang, A. Guleri

    
  • ·P29.34 MRSA screening in cardiac intensive care – the Achilles’ heel: a clinical audit and survey of outcomes at Lancashire cardiac centre

    Page :S88

    M. Przybylo, S. Summers, M. Purohit, A. Guleri

    
  • ·P29.35 Prospective dialysis surveillance and recommendations for its continuance in a major teaching hospital

    Page :S89

    R. Bajwa, A. Casey, P. Conlon, F. Fitzpatrick

    
  • ·P29.36 MRSA clinical case detection is more accurate than MRSA bacteraemia rates for detecting the effect of control measures

    Page :S89

    J. Cargill, A. Sismey, A. Karas, D. Enoch

    
  • ·P29.38 Hospital acquired diarrhoea in paediatric patients: a prospective case-controlled study in a tertiary care referral hospital in North India

    Page :S89

    N. Taneja, B. Chander, G. Singh, S. Pahil, S. Singhi, S. Sharma

    

• Poster Session 31 – Tuberculosis

  • ·P31.01 Evaluation of tuberculosis case contacts study program

    Page :S90

    P. Garcia-Shimizu, C. Villanueva-Ruiz, M. Fuster-Pérez, J. Sánchez-Payá, C. Escriva-Pons, J. Barrenengoa-Sañudo, A. Rincon-Carlavilla, A. Gonzalez-Torga